Internal Medicine, Endocrinology, Diabetes, & Metabolism · Trumbull, CT
NPI
1437326147
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
112 Quarry Rd, Suite 250
Trumbull, CT, 06611
Phone (203) 371-7048
Groups this clinician bills Medicare through
Medicare paid, 2024
$642K
40,247 services
Medicare patients, 2024
558
Average age 75
Drug cost, 2024
$5.2M
6,738 prescriptions
Company payments, 2025
$272
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandi-Jo Galati was code J3111 (injection, romosozumab-aqqg, 1 mg), 19,740 times for 13 patients. In total Sandi-Jo Galati billed 40,247 services in 21 codes, and Medicare paid $642K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 19,740 | 13 | $8.56 | $169K |
| J0897 Injection, denosumab, 1 mg | Office | 18,300 | 183 | $20.49 | $375K |
| 99214 Office E&M - Established | Office | 586 | 385 | $100.51 | $59K |
| 96372 Injection Administration | Office | 446 | 200 | $11.64 | $5,193 |
| 82962 Clinical Chemistry | Office | 273 | 167 | $3.20 | $874 |
| 99213 Office E&M - Established | Office | 253 | 192 | $67.25 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 170 | 122 | $13.82 | $2,349 |
| 83037 Blood Count | Office | 169 | 122 | $9.48 | $1,602 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 75 | 15 | $4.59 | $344 |
| 95251 Test - Miscellaneous | Office | 70 | 39 | $28.49 | $1,994 |
| 76536 Ultrasound - Nonspecific | Office | 69 | 69 | $91.02 | $6,280 |
| 83036 Blood Count | Office | 45 | 41 | $9.52 | $428 |
| 99204 Office E&M - New | Office | 19 | 19 | $87.46 | $1,662 |
| 96365 Intravenous Infusion, Hydration | Office | 16 | 16 | $47.46 | $759 |
By year: 2022 $370K for 18,467 services; 2023 $456K for 23,626 services; 2024 $642K for 40,247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 273 | 167 | $3.20 | $874 |
| 83037 Blood Count | 169 | 122 | $9.48 | $1,602 |
| 83036 Blood Count | 45 | 41 | $9.52 | $428 |
Medicare prescription drug claims, 2024
In 2024, the drug Sandi-Jo Galati prescribed most often to Medicare patients was Levothyroxine Sodium, with 648 prescriptions and refills. In total Sandi-Jo Galati wrote 6,738 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 648 | 1,825 | 211 | $7,148 |
| Ozempic Semaglutide | 559 | 1,069 | 146 | $1.0M |
| Mounjaro Tirzepatide | 462 | 660 | 98 | $705K |
| Synthroid Levothyroxine Sodium | 417 | 1,066 | 114 | $45K |
| Jardiance Empagliflozin | 367 | 768 | 98 | $450K |
| Metformin Hcl Er Metformin Hcl | 285 | 821 | 98 | $3,248 |
| Tresiba Flextouch U-200 Insulin Degludec | 200 | 455 | 62 | $181K |
| Unithroid Levothyroxine Sodium | 185 | 526 | 51 | $5,055 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 175 | 390 | 72 | $16K |
| Rosuvastatin Calcium Generic | 125 | 347 | 41 | $1,171 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 123 | 323 | 37 | $181K |
| Atorvastatin Calcium Generic | 120 | 344 | 37 | $865 |
| Farxiga Dapagliflozin Propanediol | 111 | 209 | 30 | $115K |
| Trulicity Dulaglutide | 109 | 157 | 26 | $157K |
| Levoxyl Levothyroxine Sodium | 99 | 293 | 35 | $3,965 |
Brand drugs: 3,935 claims; generic drugs: 2,350 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandi-Jo Galati $272 ($272 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $272.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 16 | $272 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.